Citation: | ZHANG Wenji. Postmortem distribution of carbofuran and its main metabolite benzofuranol in rats[J]. Journal of China Pharmaceutical University, 2018, 49(6): 706-710. DOI: 10.11665/j.issn.1000-5048.20180611 |
[1] |
Yun KM.Forensic Toxicokinetics(法医毒物动力学)[M].Beijing:People′s Medical Publishing House,2015:367-367.
|
[2] |
Wang Y,Lu XG,Wang XH,et.al.In vivo determination of carbofuran level and its distribution in poisoned rabbits[J].Lab Med Clin(检验医学与临床),2016,3(22):3135-3137.
|
[3] |
Liu L.Forensic Toxicology(法医毒理学)[M].Beijing:People′s Medical Publishing House,2010:164-164.
|
[4] |
Wu MM.The forensic toxicokinetics study of carbofuran[D].Shanxi Medical University,2011.
|
[5] |
Yang H,Zhou SL,Yin ML,et al.The study on photocatalytic degradation kinetics of carbofuran[J].China Environ Sci(中国环境科学),2013,33(1):82-87.
|
[6] |
Shi YT,Ren F,Zhang P,et al.The determination of carbofuran in post mortem blood and viscera using LC-MS/MS[J].Chin J Forensic Med(中国法医学杂志),2015(4):426-427.
|
[7] |
Han E,Kim E,Hong H,et al.Evaluation of postmortem redistribution phenomena for commonly encountered drugs[J].Forensic Sci Int,2012,219(1/2/3):265-271.
|
[8] |
Fan AA,Shen YN,Zheng F,et al.The stability study of carbofuran and its metabolites in blood under different storage conditions[J].Chin J Forensic Med(中国法医学杂志),2017(6):578-582.
|
[9] |
Zhao S,Zhang YF,Wang J,et al.In vivo postmortem distribution of mepiquat chloride in rats[J].J China Pharm Univ(中国药科大学学报),2013,44(2):147-150.
|
[1] | LU Zhipeng, XU Qinglong, CHEN Panpan, QIN Yajuan, TANG Lijun, LI Tingyou. Research progress of radioprobes targeting fibroblast activating protein[J]. Journal of China Pharmaceutical University, 2022, 53(6): 651-662. DOI: 10.11665/j.issn.1000-5048.20220603 |
[2] | CHEN Xin, YANG Qian, YOU Qidong, GUO Xiaoke. Advances of inhibitors targeting MLL1-WDR5 protein-protein interaction[J]. Journal of China Pharmaceutical University, 2022, 53(2): 125-136. DOI: 10.11665/j.issn.1000-5048.20220201 |
[3] | FENG Yang, XU Xiao, MO Ran. Advances in lymphatic targeted drug delivery system for treatment of tumor metastasis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 425-432. DOI: 10.11665/j.issn.1000-5048.20200406 |
[4] | TANG Keqin, LIN Huaqing, LI Shuhong, DONG Lixin, LU Bohong, JIANG Hong. Advances in tumor targeted nanocrystals[J]. Journal of China Pharmaceutical University, 2020, 51(4): 418-424. DOI: 10.11665/j.issn.1000-5048.20200405 |
[5] | MEI Jiahao, HONG Ze, WANG Chen. Advances of drugs in targeting cGAS-STING signaling pathway[J]. Journal of China Pharmaceutical University, 2020, 51(3): 249-259. DOI: 10.11665/j.issn.1000-5048.20200301 |
[6] | JIANG Lu, CHEN Dandan, SUN Minjie, PING Qineng, ZHANG Can. Advances of wax matrix tablets[J]. Journal of China Pharmaceutical University, 2016, 47(4): 497-502. DOI: 10.11665/j.issn.1000-5048.20160418 |
[7] | YAO Guilin, WANG Haiyong, LU Tao. Advances of the uricosuric drugs[J]. Journal of China Pharmaceutical University, 2016, 47(4): 491-496. DOI: 10.11665/j.issn.1000-5048.20160417 |
[8] | ZHANG Fangrong, WANG Wei. Advances of synthetic lipoproteins as drug nanovectors[J]. Journal of China Pharmaceutical University, 2016, 47(2): 148-157. DOI: 10.11665/j.issn.1000-5048.20160204 |
[9] | LIU Fang, SUN Haopeng, YOU Qidong. Advances in small-molecule inhibitors targeting Hsp90-Cdc37 protein-protein interaction[J]. Journal of China Pharmaceutical University, 2015, 46(3): 272-278. DOI: 10.11665/j.issn.1000-5048.20150303 |
[10] | WANG Yazhe, ZHOU Jianping, DING Yang, WANG Wei. Advances in research of biomimetic drug delivery systems[J]. Journal of China Pharmaceutical University, 2014, 45(3): 267-273. DOI: 10.11665/j.issn.1000-5048.20140303 |